Kidney Transplantation
509
37
50
312
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
82 trials with published results (16%)
Research Maturity
312 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.7%
39 terminated out of 509 trials
88.9%
+2.4% vs benchmark
33%
168 trials in Phase 3/4
26%
82 of 312 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 312 completed trials
Clinical Trials (509)
Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients
Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects
The Adaptive Platform Trial for Kidney Disease
Evolution of Physical Frailty and Patient-Reported Outcome Measures in Kidney Transplant Candidates: A Mixed-Methods Longitudinal Study Protocol
Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.
Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients
Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney Transplantation
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
Muscle Ultrasound for Sarcopenia Assessment in Kidney Transplant Recipients
Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation.
Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
Kidney Transplant Improvement Through New Exercise Training to Increase Capacity
Observational Cohort Study Renal Transplantation University Hospitals Leuven
Testing the Feasibility of a Self-Management Support Program for Patient With Chronic Diseases in Israel
Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation